CARDIOVASCULAR SYSTEMS INC (CSII)

US1416191062 - Common Stock

20  +0.03 (+0.15%)

After market: 20 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025
Revenue
YoY % growth
236.5M
-4.64%		258.973M
9.50%		236.222M
-8.79%		262.33M
11.05%
EBITDA
YoY % growth
-22.62M
-953.58%		-7.621M
66.31%		-30.777M
-303.84%		-5.018M
83.70%
EBIT
YoY % growth
-26.8M
-3,250.00%		-11.933M
55.47%		-35.806M
-200.06%		-27.914M
22.04%
Operating Margin
-11.33%-4.61%-15.16%-10.64%
EPS
YoY % growth
-0.78
-3,800.00%		-0.26
66.67%		-0.95
-265.38%		-0.68
28.21%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 23 Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		-0.13
46.14%
Revenue
Q2Q % growth		66.251M
17.84%
EBITDA
Q2Q % growth		334.56K
EBIT
Q2Q % growth		-5.44M
43.61%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2023
Q2Q % growth		 -0.20
13.04%		-0.16-0.04-28.27%
Q1 2023
Q2Q % growth		 -0.27
-22.73%		-0.23-0.04-15.09%
Q4 2022
Q2Q % growth		 -0.25
-78.57%		-0.22-0.03-12.26%
Q3 2022
Q2Q % growth		 -0.25
-257.14%		-0.290.0413.04%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2023
Q2Q % growth		 61.453M
3.92%		64.341M-2.888M-4.49%
Q1 2023
Q2Q % growth		 59.673M
2.23%		60.328M-655K-1.09%
Q4 2022
Q2Q % growth		 62.496M
-11.96%		64.226M-1.73M-2.69%
Q3 2022
Q2Q % growth		 56.221M
-11.14%		58.527M-2.306M-3.94%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 7.9% 0% 1.53%
Revenue0% 0.19% 0% -0.56%